TCL Archive Reinventing NCI: Clinical Trials System Changes Not Easy Or Quick, Klausner Says; NCAB Members, Others, Sound Off On Group’s Report October 10, 1997
TCL Archive NCI Natural Product Drug Development To Get New Emphasis; Suggestions Of Critic Accepted March 19, 1976
TCL Archive NCI Clamps Down On Site Visits, Announces New Policy To Reduce Number, Improve Quality April 26, 1974
TCL Archive White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns. September 30, 2005
TCL Archive Senate Authorizes $30 Million For Childhood Cancer Clinical Trials Research. July 18, 2008
